Evidence map›Paper›PMID 40662587›Full record

ArticleASAIO journal (American Society for Artificial Internal Organs : 1992)2025

High-Concentration Hydrogen Delivery During Dialysis Using an Innovative Direct Dissolution Technique: In Vivo Kinetics in a Canine Model.

Masaki Shibuya, Masafumi Fujinaka, Mako Yonezawa, Natsumi Nishimura, Hitoshi Uchinoumi, Kenji Tani, Yukihiro Hitaka, Kimihiko Nakamura, Naohito Isoyama, Zenzo Fujii and 1 more

Abstract read
In one paragraph

Article in ASAIO journal (American Society for Artificial Internal Organs : 1992), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Masaki ShibuyaFrom the Department of Medicine and Clinical Science, Graduate School of Medicine, Yamaguchi University, Ube, Japan.ORCID 0000-0001-8476-9447
Masafumi FujinakaFrom the Department of Medicine and Clinical Science, Graduate School of Medicine, Yamaguchi University, Ube, Japan.
Mako YonezawaFrom the Department of Medicine and Clinical Science, Graduate School of Medicine, Yamaguchi University, Ube, Japan.
Natsumi NishimuraFrom the Department of Medicine and Clinical Science, Graduate School of Medicine, Yamaguchi University, Ube, Japan.
Hitoshi UchinoumiFrom the Department of Medicine and Clinical Science, Graduate School of Medicine, Yamaguchi University, Ube, Japan.
Kenji TaniLaboratory of Veterinary Surgery, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan.
Yukihiro HitakaDepartment of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Japan.
Kimihiko NakamuraDepartment of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Japan.
Naohito IsoyamaDepartment of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Japan.
Zenzo FujiiDepartment of Nephrology, St Hill Hospital, Ube, Japan.
Motoaki SanoFrom the Department of Medicine and Clinical Science, Graduate School of Medicine, Yamaguchi University, Ube, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydrogen gas (H₂) shows broad therapeutic potential. Hemodialysis, using large dialysate volumes in contact with blood, presents a promising H₂ delivery method. We developed an innovative system generating hydrogen-enriched dialysate, differing from conventional electrolysis. This system directly dissolves H₂ gas into tap water to produce saturated water, which then undergoes reverse osmosis (RO) for dialysate preparation. Using this system in a canine hemodialysis model with a single dog, we measured H₂ concentrations. High H₂ levels were consistently maintained (approximately 1,600 ppb in RO water; stable approximately 230 ppb in final dialysate). H₂ efficiently diffused into the extracorporeal blood circuit, with outlet concentrations reaching 54.0-67.7% of the dialysate level. However, low systemic arterial concentrations (pulmonary, carotid) indicated significant pulmonary clearance, suggesting H₂ primarily acts locally within the circuit and dialyzer. Compared with traditional electrolyzed water methods, this direct dissolution system delivers substantially higher and more stable H₂ concentrations. Its simpler design and potentially lower installation costs suggest feasibility for widespread clinical adoption. Future studies should explore hemodiafiltration (HDF) to potentially enhance systemic H₂ delivery and evaluate long-term clinical benefits.

Indexed as

HydrogenRenal DialysisAnimalsDogsKineticsHydrogencanine modeldirect dissolutionhydrogen-enriched dialysate

Identifiers

PMID40662587
PMCPMC12382731

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.